FIDELMED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FIDELMED
Largest movements
- Cash +€321,066
up €321,066 (+319.9%), from €100,351 to €421,418
mainly Contributions, distributions and other (+€2.6m) and Trade debts (+€714,191)
- Receivables within one year +€256,724
up €256,724 (+16.3%), from €1.6m to €1.8m
of which Other amounts receivable: +€254,482
- Intangible fixed assets +€89,204
up €89,204 (+32.8%), from €271,868 to €361,072
- Stocks and contracts +€49,939
up €49,939 (+40.0%), from €124,769 to €174,709
- Contributions +€2.6m
up €2.6m (+85.2%), from €3.0m to €5.6m
- Profit (loss) carried forward -€1.7m
down €1.7m (-50.7%), from -€3.3m to -€4.9m
- Trade debts +€714,191
up €714,191 (+93.3%), from €765,747 to €1.5m
- Debts after one year -€593,554
down €593,554 (-47.6%), from €1.2m to €653,522
- Other debts -€406,746
down €406,746 (-85.5%), from €475,909 to €69,163
- Gross operating margin -€148,275
down €148,275 (-12.6%), from -€1.2m to -€1.3m
- Staff costs +€121,670
up €121,670 (+143.3%), from €84,891 to €206,561
- Other operating charges -€30,700
down €30,700 (-87.5%), from €35,086 to €4,386
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,354,774 | €3,070,029 | +€715,255 | +30.4% |
| Fixed assets | 21/28 | €539,858 | €625,987 | +€86,129 | +16.0% |
| Intangible fixed assets | 21 | €271,868 | €361,072 | +€89,204 | +32.8% |
| Tangible fixed assets | 22/27 | €26,706 | €22,281 | -€4,425 | -16.6% |
| Plant, machinery and equipment | 23 | €7,394 | €7,531 | +€136 | +1.8% |
| Furniture and vehicles | 24 | €11,935 | €8,333 | -€3,601 | -30.2% |
| Other tangible fixed assets | 26 | €7,377 | €6,417 | -€960 | -13.0% |
| Financial fixed assets | 28 | €241,284 | €242,633 | +€1,350 | +0.6% |
| Current assets | 29/58 | €1,814,917 | €2,444,043 | +€629,126 | +34.7% |
| Stocks and contracts in progress | 3 | €124,769 | €174,709 | +€49,939 | +40.0% |
| Stocks | 30/36 | €124,769 | €174,709 | +€49,939 | +40.0% |
| Amounts receivable within one year | 40/41 | €1,579,130 | €1,835,854 | +€256,724 | +16.3% |
| Trade receivables | 40 | €255,048 | €257,290 | +€2,242 | +0.9% |
| Other amounts receivable | 41 | €1,324,082 | €1,578,563 | +€254,482 | +19.2% |
| Cash at bank and in hand | 54/58 | €100,351 | €421,418 | +€321,066 | +319.9% |
| Deferred charges and accrued income | 490/1 | €10,666 | €12,063 | +€1,397 | +13.1% |
| Total equity and liabilities | 10/49 | €2,354,774 | €3,070,029 | +€715,255 | +30.4% |
| Equity | 10/15 | -€268,413 | €636,115 | +€904,528 | |
| Contributions | 10/11 | €3,011,648 | €5,578,801 | +€2.6m | +85.2% |
| Capital | 10 | €3,011,648 | €5,578,801 | +€2.6m | +85.2% |
| Issued capital | 100 | €3,011,648 | €5,578,801 | +€2.6m | +85.2% |
| Profit (loss) carried forward | 14 | -€3,280,061 | -€4,942,685 | -€1.7m | -50.7% |
| Amounts payable | 17/49 | €2,623,187 | €2,433,914 | -€189,273 | -7.2% |
| Amounts payable after more than one year | 17 | €1,247,076 | €653,522 | -€593,554 | -47.6% |
| Financial debts | 170/4 | €1,247,076 | €653,522 | -€593,554 | -47.6% |
| Amounts payable within one year | 42/48 | €1,376,043 | €1,778,837 | +€402,795 | +29.3% |
| Current portion of amounts payable after more than one year | 42 | €117,104 | €193,438 | +€76,334 | +65.2% |
| Trade debts | 44 | €765,747 | €1,479,939 | +€714,191 | +93.3% |
| Suppliers | 440/4 | €765,747 | €1,479,939 | +€714,191 | +93.3% |
| Taxes, remuneration and social security | 45 | €17,283 | €36,298 | +€19,015 | +110.0% |
| Taxes | 450/3 | €2,099 | €7,591 | +€5,492 | +261.6% |
| Remuneration and social security | 454/9 | €15,184 | €28,707 | +€13,523 | +89.1% |
| Other amounts payable | 47/48 | €475,909 | €69,163 | -€406,746 | -85.5% |
| Accrued charges and deferred income | 492/3 | €69 | €1,555 | +€1,486 | +2167.6% |
| Remuneration, social security and pensions | 62 | €84,891 | €206,561 | +€121,670 | +143.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €78,342 | €89,660 | +€11,318 | +14.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €431 | €8,713 | +€8,282 | +1923.0% |
| Other operating charges | 640/8 | €35,086 | €4,386 | -€30,700 | -87.5% |
| Gross operating margin | 9900 | -€1,177,545 | -€1,325,820 | -€148,275 | -12.6% |
| Operating profit (loss) | 9901 | -€1,376,295 | -€1,635,139 | -€258,845 | -18.8% |
| Financial income | 75/76B | €8,677 | €3,970 | -€4,707 | -54.2% |
| Recurring financial income | 75 | €8,677 | €3,970 | -€4,707 | -54.2% |
| Financial charges | 65/66B | €23,247 | €30,724 | +€7,476 | +32.2% |
| Recurring financial charges | 65 | €23,247 | €30,724 | +€7,476 | +32.2% |
| Profit (loss) for the period before taxes | 9903 | -€1,390,864 | -€1,661,892 | -€271,028 | -19.5% |
| Income taxes | 67/77 | €2,124 | €732 | -€1,392 | -65.5% |
| Profit (loss) for the period | 9904 | -€1,392,988 | -€1,662,625 | -€269,637 | -19.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€1,392,988 | -€1,662,625 | -€269,637 | -19.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.